会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 81. 发明申请
    • ETHERNET LINK AGGREGATION
    • 以太网链路聚合
    • US20120257507A1
    • 2012-10-11
    • US13529371
    • 2012-06-21
    • Masakazu SatoSatoshi NakajimaKazunari Suzuki
    • Masakazu SatoSatoshi NakajimaKazunari Suzuki
    • H04L12/24
    • H04L45/245H04L12/413H04L45/745H04L49/351H04L61/2092H04L69/22H04W84/18Y02D50/30
    • A system and method of transmitting data across a first link aggregation formed by an intermediate switch and a downstream switch, the intermediate switch adopting a Media-Access Card (MAC)-address-based load sharing algorithm for distributing traffic among links to the downstream switch interfaced with a final destination device. The method comprises: receiving a packet having a MAC header and an IP header at an input port of an upstream switch for transmission from the upstream switch to the intermediate switch, the upstream switch and intermediate switch forming a second link aggregation; re-writing, at the upstream switch, the source MAC address of the received packet to a different source address; sending the packet through the second link aggregation to the intermediate switch, the intermediate switch implementing the load sharing algorithm for sending the packet to the downstream switch along a link through the first link aggregation to the destination device.
    • 一种通过中间交换机和下游交换机形成的第一链路聚合发送数据的系统和方法,所述中间交换机采用基于媒体接入卡(MAC)地址的负载分担算法,用于在下游交换机的链路之间分配业务 与最终目的地设备连接。 该方法包括:在上游交换机的输入端口接收具有MAC报头和IP报头的分组,从上游交换机向中间交换机发送,上游交换机和中间交换机形成第二链路聚合; 在上游交换机上重新写入接收到的数据包的源MAC地址到不同的源地址; 将所述分组通过所述第二链路聚合发送到所述中间交换机,所述中间交换机实现负载分担算法,用于通过所述第一链路聚合向所述目的设备沿着链路向所述下游交换机发送所述分组。
    • 82. 发明授权
    • Sliding assistance mechanism and pull-in unit
    • 滑动辅助机构和拉入单元
    • US08272167B2
    • 2012-09-25
    • US12312431
    • 2007-11-12
    • Masakazu Sato
    • Masakazu Sato
    • E05D15/06
    • E05F5/003E05B17/0025E05B63/0052E05B65/0817E05C2007/007E05F1/16E05Y2201/412E05Y2201/424E05Y2600/45E05Y2600/46E05Y2800/00E05Y2800/24Y10T74/18808Y10T74/20
    • A sliding assistance mechanism for helping a switching operation of a moving body on a main body side, includes a case attached to the main body side; first and second moving members slidably placed in the case, respectively; a pair of latches pivotally supported at each moving member, respectively, and releasably locked to corresponding parts of a case side; an urging device provided between both moving members; and a guide groove provided in the case for moving the latches along the same; and first and second operational members spaced apart from each other and provided in the moving body. When the moving members are at a halfway position, an engagement of one of the latches with the second operational member provided in the second moving member is released, and the moving body is pulled by the urging device to the second position.
    • 一种用于帮助移动体在主体侧的切换操作的滑动辅助机构包括附接到主体侧的壳体; 第一和第二移动构件分别可滑动地放置在壳体中; 一对闩锁,分别枢转地支撑在每个移动构件上,并可释放地锁定到壳体侧的对应部分; 设置在两个移动构件之间的推动装置; 以及设置在所述壳体中的引导槽,用于沿着所述壳体移动所述闩锁; 以及第一和第二操作构件,其彼此间隔开并设置在移动体中。 当移动构件处于中途位置时,释放一个闩锁与设置在第二移动构件中的第二操作构件的接合,并且移动体被推动装置拉动到第二位置。
    • 85. 发明授权
    • Triazole derivative
    • 三唑衍生物
    • US08022091B2
    • 2011-09-20
    • US12278054
    • 2007-02-05
    • Naoya OnoTetsuo TakayamaFumiyasu ShiozawaHironori KatakaiTetsuya YabuuchiTomomi OtaMakoto YagiMasakazu Sato
    • Naoya OnoTetsuo TakayamaFumiyasu ShiozawaHironori KatakaiTetsuya YabuuchiTomomi OtaMakoto YagiMasakazu Sato
    • A01N43/64A61K31/41C07D249/12
    • C07D249/08
    • An object of the present invention is to provide a compound having an action of inhibiting binding between S1P and its receptor, Edg-1 (S1P1), and is useful as a pharmaceutical compound. A compound or a pharmaceutically acceptable salt thereof, which compound is represented by the formula below (where A represents an oxygen atom, a sulfur atom, a group represented by Formula —SO—, a group represented by Formula —SO2—, or the like, R1 represents a hydrogen atom, an alkyl group having 1-6 carbon atoms, or the like, R1A represents a hydrogen atom or the like, R2 represents an alkyl group having 1-6 carbon atoms, a cycloalkyl group having 3-6 carbon atoms, or the like, R3 represents an aryl group, R4 represents a hydrogen atom or an alkyl group having 1-6 carbon atoms and optionally substituted with a carboxyl group, and R5 represents an alkyl group having 1-10 carbon atoms, a cycloalkyl group having 3-8 carbon atoms, an aryl group which is optionally substituted, or the like).
    • 本发明的目的是提供具有抑制S1P与其受体Edg-1(S1P1)结合的作用的化合物,可用作药物化合物。 化合物或其药学上可接受的盐,其化合物由下式表示(其中A表示氧原子,硫原子,由式-SO-表示的基团,由式-SO2-表示的基团等) R1表示氢原子,具有1-6个碳原子的烷基等,R1A表示氢原子等,R2表示具有1-6个碳原子的烷基,具有3-6个碳原子的环烷基 原子等,R 3表示芳基,R 4表示氢原子或具有1-6个碳原子并且任选被羧基取代的烷基,R 5表示具有1-10个碳原子的烷基,环烷基 具有3-8个碳原子的基团,任选取代的芳基等)。